Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Cencora, Inc. (COR) Insider Trading Activity
Healthcare • Medical Distribution • 46,000 employees
Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Total Value
-$1,124,341,056.67
Total Shares
-4,310,836
Average Trade Value
-$13,711,476.30
Most Active Insider
Walgreens Boots Alliance, Inc.
Total Activity: $1,067,646,416
Largest Single Transaction
$1,067,646,416
by Walgreens Boots Alliance, Inc. on Aug 1, 2024
30-Day Activity
12 Transactions
Volume: 8,168 shares
Value: $3,685,062
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
Executive Vice President
Officer
|
Dec 20, 2024 | 1,678 | $383,792 | 20,329 (-8.3%) | Sale | |
|
President CEO
Director, Officer
|
Dec 18, 2024 | 789 | $0 | 53,603 (+1.5%) | Exercise/Conversion | |
|
Chief Financial Officer
Officer
|
Dec 18, 2024 | 207 | $48,074 | 149,293 (-0.1%) | Payment of Exercise Price | |
|
Chief Financial Officer
Officer
|
Dec 18, 2024 | 207 | $0 | 149,500 (+0.1%) | Exercise/Conversion | |
|
SVP Chief Accounting Officer
Officer
|
Dec 18, 2024 | 108 | $25,082 | 21,988 (-0.5%) | Payment of Exercise Price | |
|
Executive Chairman
Director, Officer
|
Dec 18, 2024 | 395 | $91,735 | 321,912 (-0.1%) | Payment of Exercise Price | |
|
President CEO
Director, Officer
|
Dec 18, 2024 | 789 | $183,237 | 52,814 (-1.5%) | Payment of Exercise Price | |
|
SVP Chief Accounting Officer
Officer
|
Dec 18, 2024 | 108 | $0 | 22,096 (+0.5%) | Exercise/Conversion | |
|
Executive Chairman
Director, Officer
|
Dec 18, 2024 | 395 | $0 | 322,307 (+0.1%) | Exercise/Conversion | |
|
SVP Chief Accounting Officer
Officer
|
Dec 3, 2024 | 1,816 | $454,754 | 21,988 (-8.3%) | Sale | |
|
Chief Financial Officer
Officer
|
Nov 27, 2024 | 22,215 | $5,533,090 | 149,293 (-14.9%) | Payment of Exercise Price | |
|
Chief Financial Officer
Officer
|
Nov 27, 2024 | 33,877 | $3,034,702 | 171,508 (+19.8%) | Exercise/Conversion | |
|
Executive Chairman
Director, Officer
|
Nov 25, 2024 | 50,000 | $12,198,750 | 326,556 (-15.3%) | Sale | |
|
Chief Financial Officer
Officer
|
Nov 21, 2024 | 16,248 | $3,657,100 | 137,631 (-11.8%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Nov 21, 2024 | 14,276 | $10,000 | 28,225 (+50.6%) | Grant | |
|
SVP Chief Accounting Officer
Officer
|
Nov 21, 2024 | 792 | $178,263 | 23,804 (-3.3%) | Payment of Exercise Price | |
|
President CEO
Director, Officer
|
Nov 21, 2024 | 38,433 | $10,000 | 69,529 (+55.3%) | Grant | |
|
Executive Vice President
Officer
|
Nov 21, 2024 | 6,218 | $1,399,547 | 22,007 (-28.3%) | Payment of Exercise Price | |
|
Executive Chairman
Director, Officer
|
Nov 21, 2024 | 53,723 | $12,091,973 | 376,556 (-14.3%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Nov 21, 2024 | 13,177 | $10,000 | 24,832 (+53.1%) | Grant | |
|
Executive Vice President
Officer
|
Nov 21, 2024 | 6,094 | $1,371,638 | 18,738 (-32.5%) | Payment of Exercise Price | |
|
Executive Chairman
Director, Officer
|
Nov 21, 2024 | 123,528 | $0 | 430,279 (+28.7%) | Grant | |
|
Chief Financial Officer
Officer
|
Nov 21, 2024 | 35,137 | $0 | 153,879 (+22.8%) | Grant | |
|
President CEO
Director, Officer
|
Nov 21, 2024 | 16,715 | $3,762,212 | 52,814 (-31.6%) | Payment of Exercise Price | |
|
SVP Chief Accounting Officer
Officer
|
Nov 21, 2024 | 1,831 | $0 | 24,596 (+7.4%) | Grant | |
|
Executive Chairman
Director, Officer
|
Nov 19, 2024 | 21,509 | $1,926,776 | 328,260 (+6.6%) | Exercise/Conversion | |
|
Executive Chairman
Director, Officer
|
Nov 19, 2024 | 21,509 | $5,208,619 | 306,751 (-7.0%) | Sale | |
|
Executive Vice President
Officer
|
Nov 8, 2024 | 1,829 | $10,000 | 12,227 (+15.0%) | Exercise/Conversion | |
|
Executive Chairman
Director, Officer
|
Nov 8, 2024 | 4 | $994 | 302,364 (-0.0%) | Payment of Exercise Price | |
|
Executive Chairman
Director, Officer
|
Nov 8, 2024 | 3,067 | $761,873 | 306,751 (-1.0%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Nov 8, 2024 | 1,264 | $0 | 13,889 (+9.1%) | Exercise/Conversion | |
|
Chief Financial Officer
Officer
|
Nov 8, 2024 | 2,132 | $0 | 119,678 (+1.8%) | Exercise/Conversion | |
|
President CEO
Director, Officer
|
Nov 8, 2024 | 3,578 | $0 | 32,568 (+11.0%) | Exercise/Conversion | |
|
Executive Vice President
Officer
|
Nov 8, 2024 | 632 | $156,995 | 10,398 (-6.1%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Nov 8, 2024 | 572 | $142,091 | 11,655 (-4.9%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Nov 8, 2024 | 2,971 | $0 | 13,919 (+21.3%) | Exercise/Conversion | |
|
Chief Financial Officer
Officer
|
Nov 8, 2024 | 1,570 | $390,004 | 115,891 (-1.4%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Nov 8, 2024 | 1,294 | $321,443 | 12,625 (-10.2%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Nov 8, 2024 | 473 | $117,498 | 13,949 (-3.4%) | Payment of Exercise Price | |
|
Chief Financial Officer
Officer
|
Nov 8, 2024 | 936 | $232,512 | 118,742 (-0.8%) | Payment of Exercise Price | |
|
President CEO
Director, Officer
|
Nov 8, 2024 | 4,215 | $0 | 30,725 (+13.7%) | Exercise/Conversion | |
|
Executive Vice President
Officer
|
Nov 8, 2024 | 551 | $136,874 | 13,338 (-4.1%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Nov 8, 2024 | 1,084 | $0 | 14,422 (+7.5%) | Exercise/Conversion | |
|
Chief Financial Officer
Officer
|
Nov 8, 2024 | 3,395 | $0 | 117,461 (+2.9%) | Exercise/Conversion | |
|
President CEO
Director, Officer
|
Nov 8, 2024 | 1,735 | $430,991 | 28,990 (-6.0%) | Payment of Exercise Price | |
|
SVP Chief Accounting Officer
Officer
|
Nov 8, 2024 | 375 | $93,154 | 21,858 (-1.7%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Nov 8, 2024 | 1,274 | $0 | 9,578 (+13.3%) | Exercise/Conversion | |
|
Executive Chairman
Director, Officer
|
Nov 8, 2024 | 11,936 | $0 | 297,024 (+4.0%) | Exercise/Conversion | |
|
Executive Chairman
Director, Officer
|
Nov 8, 2024 | 7,454 | $10,000 | 309,818 (+2.4%) | Exercise/Conversion | |
|
President CEO
Director, Officer
|
Nov 8, 2024 | 1,472 | $365,660 | 31,096 (-4.7%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Nov 8, 2024 | 2,023 | $0 | 11,030 (+18.3%) | Exercise/Conversion | |
|
Executive Chairman
Director, Officer
|
Nov 8, 2024 | 10,536 | $0 | 302,369 (+3.5%) | Exercise/Conversion | |
|
Chief Financial Officer
Officer
|
Nov 8, 2024 | 2,950 | $0 | 118,841 (+2.5%) | Exercise/Conversion | |
|
President CEO
Director, Officer
|
Nov 8, 2024 | 1,616 | $401,431 | 26,510 (-6.1%) | Payment of Exercise Price | |
|
SVP Chief Accounting Officer
Officer
|
Nov 8, 2024 | 1,061 | $0 | 21,103 (+5.0%) | Exercise/Conversion | |
|
SVP Chief Accounting Officer
Officer
|
Nov 8, 2024 | 303 | $75,268 | 20,800 (-1.5%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Nov 8, 2024 | 571 | $141,842 | 9,007 (-6.3%) | Payment of Exercise Price | |
|
Executive Chairman
Director, Officer
|
Nov 8, 2024 | 5,191 | $1,289,496 | 291,833 (-1.8%) | Payment of Exercise Price | |
|
President CEO
Director, Officer
|
Nov 8, 2024 | 3,714 | $0 | 28,126 (+13.2%) | Exercise/Conversion | |
|
Chief Financial Officer
Officer
|
Nov 8, 2024 | 1,295 | $321,691 | 117,546 (-1.1%) | Payment of Exercise Price | |
|
SVP Chief Accounting Officer
Officer
|
Nov 8, 2024 | 1,433 | $0 | 22,233 (+6.4%) | Exercise/Conversion | |
|
SVP Chief Accounting Officer
Officer
|
Nov 8, 2024 | 1,229 | $10,000 | 23,087 (+5.3%) | Exercise/Conversion | |
|
SVP Chief Accounting Officer
Officer
|
Nov 8, 2024 | 322 | $79,988 | 22,765 (-1.4%) | Payment of Exercise Price | |
|
Director
|
Nov 1, 2024 | 107 | $25,067 | 1,883 (+5.7%) | Grant | |
|
Director
|
Nov 1, 2024 | 368 | $86,211 | 368 (+100.0%) | Grant | |
|
Director
|
Nov 1, 2024 | 134 | $31,392 | 12,218 (+1.1%) | Grant | |
|
Director
|
Nov 1, 2024 | 107 | $25,067 | 1,883 (+5.7%) | Grant | |
|
Executive Chairman
Director, Officer
|
Oct 22, 2024 | 21,509 | $5,071,822 | 285,088 (-7.5%) | Sale | |
|
Executive Chairman
Director, Officer
|
Oct 22, 2024 | 21,509 | $1,926,776 | 306,597 (+7.0%) | Exercise/Conversion | |
|
Chairman, President CEO
Director, Officer
|
Sep 17, 2024 | 21,509 | $5,183,884 | 285,088 (-7.5%) | Sale | |
|
Chairman, President CEO
Director, Officer
|
Sep 17, 2024 | 21,509 | $1,926,776 | 306,597 (+7.0%) | Exercise/Conversion | |
|
Chairman, President CEO
Director, Officer
|
Aug 20, 2024 | 10,754 | $963,343 | 295,842 (+3.6%) | Exercise/Conversion | |
|
Chairman, President CEO
Director, Officer
|
Aug 20, 2024 | 10,754 | $2,571,604 | 285,088 (-3.8%) | Sale | |
|
Executive Vice President
Officer
|
Aug 6, 2024 | 1,473 | $357,482 | 10,948 (-13.5%) | Sale | |
|
Director
|
Aug 1, 2024 | 128 | $31,291 | 12,084 (+1.1%) | Grant | |
| Aug 1, 2024 | 4,438,171 | $1,067,646,416 | 19,980,000 (-22.2%) | Sale | ||
|
Director
|
Aug 1, 2024 | 103 | $25,179 | 1,776 (+5.8%) | Grant | |
|
Director
|
Aug 1, 2024 | 103 | $25,179 | 1,776 (+5.8%) | Grant | |
|
Chairman, President CEO
Director, Officer
|
Jul 16, 2024 | 10,755 | $2,388,901 | 285,088 (-3.8%) | Sale | |
|
Chairman, President CEO
Director, Officer
|
Jul 16, 2024 | 10,755 | $963,433 | 295,843 (+3.6%) | Exercise/Conversion | |
|
EVP Chief Strategy Officer
Officer
|
Jul 1, 2024 | 1,432 | $0 | 9,990 (+14.3%) | Exercise/Conversion | |
|
EVP Chief Strategy Officer
Officer
|
Jul 1, 2024 | 533 | $124,471 | 9,457 (-5.6%) | Payment of Exercise Price |